The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

1. Leskelä, S.
2. Leandro-García, L.J.
3. Mendiola, M.
4. Barriuso, J.
5. Inglada-Pérez, L.
6. Muñoz, I.
7. Martínez-Delgado, B.
8. Redondo, A.
9. De Santiago, J.
10. Robledo, M.
11. Hardisson, D.
12. Rodríguez-Antona, C.